Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≥20-≤50
EC/CAS
1675-54-3
Name of the chemical
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
Concentration
≥10-≤20
EC/CAS
64742-95-6
Name of the chemical
Solvent naphtha (petroleum), light arom
Concentration
≥5.0-≤8.1
EC/CAS
141-78-6
Name of the chemical
acetic acid, ethyl ester
Concentration
≥5.0-≤7.4
EC/CAS
108-88-3
Name of the chemical
Toluene
Concentration
≥1.0-≤4.4
EC/CAS
21645-51-2
Name of the chemical
Aluminium hydroxide
Concentration
≥1.0-≤5.0
EC/CAS
98-82-8
Name of the chemical
Cumol (2022/692)
Concentration
<1.0
General Information
Version
17.02
Revision date
2023-08-14
Product name
01W090 BASE COMPONENT
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Aerospace PRC-DeSoto
Icons in SDS
Company Information
company name
PPG Aerospace PRC-DeSoto
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H315, H317, H319, H350, H361, H373
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture FLAMMABLE LIQUIDS - Category 2 SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 1B TOXIC TO REPRODUCTION - Category 2 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 9.7% (oral), 15.1% (dermal), 42.5% (inhalation)
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapor. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H350 - May cause cancer. H361 - Suspected of damaging fertility or the unborn child. H373 - May cause damage to organs through prolonged or repeated exposure.
Prevention
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing and eye or face protection. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P260 - Do not breathe vapor. P264 - Wash thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace.
Response
P308 + P313 - IF exposed or concerned: Get medical advice or attention. P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P302 + P352 - IF ON SKIN: Wash with plenty of water. P333 + P313 - If skin irritation or rash occurs: Get medical advice or attention. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical advice or attention.
Storage
P405 - Store locked up.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Other hazards which do not result in classification
May form explosive peroxides. Hazardous reactions or instability may occur under certain conditions of storage or use. Prolonged or repeated contact may dry skin and cause irritation. Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. Emits toxic fumes when heated. See toxicological information (Section 11)
2.1 Classification of the substance or mixture
FLAMMABLE LIQUIDS - Category 2 substance or mixture SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 1B TOXIC TO REPRODUCTION - Category 2 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 9.7% (oral), 15.1% (dermal), 42.5% (inhalation)